Bausch Health's Joe Papa resigns from board, John Paulson named chairperson [MarketWatch]
Bausch + Lomb Corporation (BLCO)
Company Research
Source: MarketWatch
The specialty pharmaceutical company named John Paulson as its chairperson of the board. The company said Papa's resignation from the board "was not due to any dispute or disagreement" with management or with the company's operations or policies. Papa had stepped down from his role of chief executive officer in May , and was succeeded by Thomas Appio. Papa was slated to be chairperson and CEO of Bausch + Lomb following the initial public offering of the Bausch + Lomb eye health business. Paulson is the president of investment management company Paulson & Co. Bausch Health's stock, which was still inactive in premarket trading, has tumbled 73.7% year to date, while the S&P 500 SPX, has dropped 20.4%. Read Next About the Author Tomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter @TomiKilgore.
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation news events
Weekly update
A roundup of the hottest topics
BLCO
News
- Bausch + Lomb Co. (NYSE: BLCO) had its price target lowered by analysts at Royal Bank of Canada from $20.00 to $18.00. They now have an "outperform" rating on the stock.MarketBeat
- Nicox Provides First Quarter 2024 Update and Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling ProgramsBusiness Wire
- Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1 [Yahoo! Finance]Yahoo! Finance
BLCO
Earnings
- 2/21/24 - Beat
BLCO
Sec Filings
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- BLCO's page on the SEC website